NEW YORK, Nov. 28, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Pain Management Therapeutics Market to 2017 - Price Competition to Intensify Following Patent Expiries of Lyrica and Cymbalta
GBI Research, the leading business intelligence provider, has released its latest research, "Pain Management Therapeutics Market to 2017 - Price Competition to Intensify Following Patent Expiries of Lyrica and Cymbalta", which provides insights into the global pain management therapeutics market and market forecasts until 2017. The report provides an in-depth analysis of the top eight therapeutic indications for which pain management drugs are often prescribed, which includes fibromyalgia, neuropathic pain, migraine, cancer pain, osteoarthritis pain, rheumatoid arthritis pain, low back pain and post-operative pain. The report also examines the global pain management therapeutics treatment usage patterns for the covered indications. In addition, the report also includes insights into the pain management therapeutics R&D pi
Copyright©2010 PR Newswire.
All rights reserved